Responsiveness of Lower Airways in Adult Patients (18-60 Years) With Stable Asthma After Treatment With Ciclesonide and Fluticasone Propionate (BY9010/NL-101)

Exclusion Criteria

• •Clinically relevant abnormal laboratory values
• •Concomitant severe diseases, diseases expected to interfere with the outcome of the study and diseases which are contra-indications for the use of inhaled steroids
• •Chronic obstructive pulmonary disease (COPD) and /or other relevant lung diseases
• •One asthma exacerbation within 2 months or more than 3 exacerbations within the last year prior to baseline visit
• •Current smokers or ex-smokers with more than 10 pack years, or having smoked within 1 year prior to baseline visit
• •Positive response to saline challenge at baseline visits
• •Positive bronchial hyperresponsiveness